Venture Life Group plc (AIM:VLG)
56.00
+1.00 (1.82%)
Oct 31, 2025, 4:35 PM GMT+1
Venture Life Group Revenue
Venture Life Group had revenue of 15.39M GBP in the half year ending June 30, 2025, a decrease of -34.39%. This brings the company's revenue in the last twelve months to 31.23M, up 95.04% year-over-year. In the year 2024, Venture Life Group had annual revenue of 26.59M with 18.90% growth.
Revenue (ttm)
31.23M
Revenue Growth
+95.04%
P/S Ratio
2.30
Revenue / Employee
726.30K
Employees
43
Market Cap
71.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.59M | 4.23M | 18.90% |
| Dec 31, 2023 | 22.37M | -21.62M | -49.15% |
| Dec 31, 2022 | 43.98M | 11.22M | 34.24% |
| Dec 31, 2021 | 32.76M | 2.69M | 8.93% |
| Dec 31, 2020 | 30.08M | 9.87M | 48.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| ConvaTec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |